| Ghrelin prevents incidence of malignant arrhythmia after acute myocardial infarction through vagal afferent nerves Y Mao, T Tokudome, K Otani, I Kishimoto, M Nakanishi, H Hosoda, ... Endocrinology 153 (7), 3426-3434, 2012 | 81 | 2012 |
| Endogenous ghrelin attenuates pressure overload–induced cardiac hypertrophy via a cholinergic anti-inflammatory pathway Y Mao, T Tokudome, I Kishimoto, K Otani, H Nishimura, O Yamaguchi, ... Hypertension 65 (6), 1238-1244, 2015 | 58 | 2015 |
| Ghrelin and blood pressure regulation Y Mao, T Tokudome, I Kishimoto Current hypertension reports 18, 1-6, 2016 | 55 | 2016 |
| Excessive sympathoactivation and deteriorated heart function after myocardial infarction in male ghrelin knockout mice Y Mao, T Tokudome, K Otani, I Kishimoto, M Miyazato, K Kangawa Endocrinology 154 (5), 1854-1863, 2013 | 51 | 2013 |
| Ghrelin as a treatment for cardiovascular diseases Y Mao, T Tokudome, I Kishimoto Hypertension 64 (3), 450-454, 2014 | 46 | 2014 |
| Hexarelin treatment in male ghrelin knockout mice after myocardial infarction Y Mao, T Tokudome, I Kishimoto, K Otani, H Hosoda, C Nagai, ... Endocrinology 154 (10), 3847-3854, 2013 | 37 | 2013 |
| Percentage of circulating CD8+ T lymphocytes is associated with albuminuria in type 2 diabetes mellitus L Lei, Y Mao, D Meng, X Zhang, L Cui, Y Huo, Y Wang Experimental and Clinical Endocrinology & Diabetes, 27-30, 2013 | 34 | 2013 |
| The cardiovascular action of hexarelin Y Mao, T Tokudome, I Kishimoto Journal of geriatric cardiology: JGC 11 (3), 253, 2014 | 32 | 2014 |
| Lack of salt-inducible kinase 2 (SIK2) prevents the development of cardiac hypertrophy in response to chronic high-salt intake S Popov, H Takemori, T Tokudome, Y Mao, K Otani, N Mochizuki, N Pires, ... PloS one 9 (4), e95771, 2014 | 25 | 2014 |
| Association of thyroid function with suicidal behavior: a systematic review and meta-analysis FJK Toloza, Y Mao, L Menon, G George, M Borikar, S Thumma, ... Medicina 57 (7), 714, 2021 | 20 | 2021 |
| Hormone treatments in congestive heart failure L Lei, Y Mao Journal of International Medical Research 46 (6), 2063-2081, 2018 | 16 | 2018 |
| Regulators of G protein signaling are up-regulated in aspirin-resistant platelets from patients with metabolic syndrome Y Mao, L Lei, J Su, Y Yu, Z Liu, Y Huo Die Pharmazie-An International Journal of Pharmaceutical Sciences 69 (5 …, 2014 | 16 | 2014 |
| Deficiency of cardiac natriuretic peptide signaling promotes peripartum cardiomyopathy-like remodeling in the mouse heart K Otani, T Tokudome, CA Kamiya, Y Mao, H Nishimura, T Hasegawa, ... Circulation 141 (7), 571-588, 2020 | 14 | 2020 |
| One dose of oral hexarelin protects chronic cardiac function after myocardial infarction Y Mao, T Tokudome, I Kishimoto, K Otani, M Miyazato, K Kangawa Peptides 56, 156-162, 2014 | 14 | 2014 |
| Daily insulin dose and cancer risk among patients with type 1 diabetes W Zhong, Y Mao JAMA oncology 8 (9), 1356-1358, 2022 | 13 | 2022 |
| Association of thyroid function with posttraumatic stress disorder: a systematic review and meta-analysis FJK Toloza, Y Mao, LP Menon, G George, M Borikar, PJ Erwin, RR Owen, ... Endocrine Practice 26 (10), 1173-1185, 2020 | 13 | 2020 |
| Total flavonoids from Astragalus alleviate endothelial dysfunction by activating the Akt/eNOS pathway Q Liu, L Zhang, Q Shan, Y Ding, Z Zhang, M Zhu, Y Mao Journal of International Medical Research 46 (6), 2096-2103, 2018 | 11 | 2018 |
| Changes of insulin resistance status and development of complications in type 1 diabetes mellitus: analysis of DCCT/EDIC study Y Mao, W Zhong Diabetes Research and Clinical Practice 184, 109211, 2022 | 10 | 2022 |
| Hypermethylation of RASAL1: a key for renal fibrosis Y Mao EBioMedicine 2 (1), 7-8, 2015 | 10 | 2015 |
| HbA1c variability as an independent risk factor for microvascular complications in type 1 diabetes Y Mao, W Zhong Journal of Diabetes Science and Technology 18 (2), 380-388, 2024 | 8 | 2024 |
Laura BrionMSL at TakedaVerified email at takeda.com
Laura BrionMSL at TakedaVerified email at takeda.com